Health

8:24 pm
Mon October 7, 2013

State exempts some meningitis outbreak records from Freedom of Information Act

Newspaper attorney says state could protect patient information by redacting names
Some state records involving the 2012 fungal meningitis outbreak remain under wraps as the Michigan Department of Community Health has declared the crisis a "medical research project." The designation makes the records exempt under the Freedom of Information Act, the state argues.
Kalamazoo River
12:19 pm
Mon September 30, 2013

State assessment finds no "long term impact" on public health from contact on Kalamazoo River

Portions of the Kalamazoo River reopened in 2012 (file photo)
Credit WMUK

The Michigan Department of Community Health says it has evaluated surface water in the area of the 2010 oil spill on the Kalamazoo River. 

Read more
9:37 am
Sun September 15, 2013

Program shows promise in reducing infant deaths in Kalamazoo County

But work remains to be done to reduce infant mortality and close racial gap
  • Source: Mlive
  • | Via: Kalamazoo Gazette
Statistics from the Michigan Department of Community Health show that from 2006 to 2010, black infants in Kalamazoo were more than five times less likely than white babies to make it to their first birthday. From 2008 to 2010, that rate was 6.4, the highest of any city in the state.
12:32 pm
Thu September 12, 2013

Racial disparity grows in infant mortality

From 2006 to 2010 infant mortality rate was five times higher for blacks in Kalamazoo
  • Source: Mlive
  • | Via: Kalamazoo Gazette
KALAMAZOO, MI - Kalamazoo is literally the land of The Promise, where a child who calls this city home can attend a Michigan college for free.
12:46 pm
Mon September 9, 2013

Kalamazoo company says drug shows potential for treating Alzheimer's Disease

Results of clinical trial being presented Monday in New jersey
  • Source: Mlive
  • | Via: Kalamazoo Gazette
KALAMAZOO, MI - A drug developed to treat diabetes also shows potential for treating Alzheimer's disease, a Kalamazoo company announced Monday, Sept. 9. Metabolic Solutions Development Co. tested the insulin sensitizer on Alzheimer's patients and found it maintained glucose metabolism in key regions of the brain affected by cognitive decline.

Pages